FTGRX | VTSMX | FTGRX / VTSMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 32 years | - |
Gain YTD | 19.841 | 18.617 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.24B | 1.72T | 0% |
Annual Yield % from dividends | 0.52 | 1.26 | 41% |
Returns for 1 year | 29.70 | 31.53 | 94% |
Returns for 3 years | 41.19 | 25.35 | 162% |
Returns for 5 years | 76.99 | 85.64 | 90% |
Returns for 10 years | 58.62 | 187.59 | 31% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FEKFX | 16.32 | 0.02 | +0.12% |
Fidelity Equity-Income K6 | |||
FBTTX | 31.30 | -0.05 | -0.16% |
Fidelity Advisor Biotechnology M | |||
TANDX | 37.82 | -0.06 | -0.16% |
Castle Tandem Institutional | |||
SHISX | 73.00 | -0.27 | -0.37% |
BlackRock Health Sciences Opps Svc | |||
AGYGX | 13.27 | -0.05 | -0.38% |
American Century Focused Global Gr Y |